J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Want to cut your energy bills? Here’s how five experts are doing it 
AUSTIN, Texas, Feb. 23, 2017 -- SmallCapVoice.com, Inc. (SCV) and Blue Marble Biomaterials announced today that Colby Underwood, Co-Chief Executive Officer / Chief Business Officer for Blue Marble Biomaterials, called in to SmallCapVoice.com to go over the Company's exciting technologies, markets, and much more. The interview outlining the company’s business strategy and future plans is now available and can be heard at http://bit.ly/2lM4BZM.
Blue Marble Biomaterials (Blue Marble), a specialty chemical manufacturer and technology provider, recently announced that it is now offering equity shares to the public through a Regulation A+ offering that is qualified by the Securities and Exchange Commission. Interested individuals can view the offering circular and find out more about the offering at https://www.manhattanstreetcapital.com/blue-marble-biomaterials.
About SmallCapVoice.com
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients' financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/
About Blue Marble Biomaterials
Blue Marble uses proprietary technologies to convert plant-based organic waste, such as used coffee grounds, wood chips, and tomato and grape pomace, into natural and non-GMO chemicals that replace chemicals derived from crude oil. www.bluemarblebio.com.
AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM https://www.sec.gov/Archives/edgar/data/1462326/000114420417009889/v459701_253g2.htm
YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.
For SmallCapVoice.com Stuart T. Smith 512-267-2430 [email protected]
